Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Targeted Oncology|August 10, 2022
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination TherapiesMatteo Santoni, Javier Molina-Cerrillo, Zin W Myint, et al.
Plos One|April 18, 2015
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?Francesco Pantano, Matteo Santoni, Giuseppe Procopio, et al.
The Oncologist|November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysisFabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Oncotarget|March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinomaDaniele Santini, Matteo Santoni, Alessandro Conti, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>RaOrazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
European Urology Oncology|June 3, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter ExperienceGiuseppina Bruno, Maria Iole Natalicchio, Marianna Garofoli, et al.
Clinical Genitourinary Cancer|August 1, 2020
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective StudyMaria Giuseppa Vitale, Stefania Pipitone, Marta Venturelli, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Pageof 15